Related Experiment Video
Updated: Jun 4, 2025

A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
Published on: January 29, 2019
Integrated multi-omics profiling reveals neutrophil extracellular traps potentiate Aortic dissection progression
Yu-Fei Zhao1,2,3,4, Zi-Ang Zuo1,2,3, Zhe-Yun Li1,2,3
1Department of Vascular Surgery, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.
Neutrophil extracellular traps (NETs) promote aortic dissection (AD) progression by orchestrating immune responses. Targeting NETs formation, specifically via citrullinated histone H3, can predict and potentially prevent adverse aortic events after endovascular repair.
Area of Science:
- Cardiovascular Biology
- Immunology
- Genomics
Background:
- Adverse aortic remodeling post-thoracic endovascular aortic repair (TEVAR) for aortic dissection (AD) increases adverse events (AAEs).
- Identifying prognostic indicators and therapeutic targets is crucial for optimizing TEVAR efficacy in AD patients.
Purpose of the Study:
- To investigate the molecular mechanisms underlying adverse aortic remodeling in AD.
- To identify novel biomarkers for predicting AAEs after TEVAR in AD patients.
Main Methods:
- Proteomic and single-cell transcriptomic analyses of peripheral blood and aortic lesions from AD patients and healthy controls.
- In vivo studies using mouse models of aortic dissection to assess the therapeutic potential of targeting NETs formation.
Main Results:
- Highly phenotype-associated macrophages orchestrate neutrophil extracellular traps (NETs) via the CXCL3/CXCR2 axis, promoting AD development.
- Increased NETs formation is a hallmark of systemic immunity and the aortic microenvironment in AD.
- Inhibition of NETs formation ameliorates AD progression and rupture in mice.
- Plasma citrullinated histone H3 levels predict AAEs following endovascular therapy.
Conclusions:
- NETs, orchestrated by macrophages through the CXCL3/CXCR2 axis, are key drivers of AD progression.
- Targeting NETs formation offers a potential therapeutic strategy for AD.
- Plasma citrullinated histone H3 serves as a valuable biomarker for risk stratification and prognostic evaluation in AD patients undergoing endovascular repair.
More Related Videos
07:18Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
Published on: May 12, 2023
07:19Author Spotlight: Quantifying Neutrophil Extracellular Traps in Disease and Drug Screening Using Dual-Color Live-Cell Imaging
Published on: December 1, 2023